|
1
|
Riccabona G and Decristoforo C: Peptide
targeted imaging of cancer. Cancer Biother Radiopharm. 18:675–687.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rudin M and Weissleder R: Molecular
imaging in drug discovery and development. Nat Rev Drug Discov.
2:123–131. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li ZJ and Cho CH: Peptides as targeting
probes against tumor vasculature for diagnosis and drug delivery. J
Transl Med. 10(Suppl 1): S12012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Caravan P: Protein-targeted
gadolinium-based magnetic resonance imaging (MRI) contrast agents:
design and mechanism of action. Acc Chem Res. 42:851–862. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitra A, Nan A, Papadimitriou JC, et al:
Polymer-peptide conjugates for angiogenesis targeted tumor
radiotherapy. Nucl Med Biol. 33:43–52. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pawar PV, Gohil SV, Jain JP, et al:
Functionalized polymersomes for biomedical applications. Polym
Chem. 4:3160–3176. 2013. View Article : Google Scholar
|
|
7
|
Seward GK, Wei Q and Dmochowski IJ:
Peptide-mediated cellular uptake of cryptophane. Bioconjug Chem.
19:2129–2135. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye F, Wu X, Jeong EK, Jia Z, et al: A
peptide targeted contrast agent specific to fibrin-fibronectin
complexes for cancer molecular imaging with MRI. Bioconjug Chem.
19:2300–2303. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen XM, Wang X, Huang Y, et al: A
comparison study of the targeting properties of NGR liposomes and
RGD-liposomes towards human umbilical vein endothelial cells. J
Chinese Pharm Sci. 18:162–169. 2009.
|
|
10
|
Beer AJ and Schwaiger M: Imaging of
integrin alphavbeta3 expression. Cancer Metastasis Rev. 27:631–644.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu S: Radiolabeled cyclic RGD peptides as
integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding
affinity via bivalency. Bioconjug Chem. 20:2200–2213.
2009.PubMed/NCBI
|
|
12
|
Dijkgraaf I, Kruijtzer JA, Liu S, et al:
Improved targeting of the alpha(v)beta(3) integrin by
multimerisation of RGD peptides. Eur J Nucl Med Mol Imaging.
34:267–273. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Haukkala J, Laitinen I, Luoto P, et al:
68Ga-DOTA-RGD peptide: biodistribution and binding into
atherosclerotic plaques in mice. Eur J Nucl Med Mol Imaging.
36:2058–2067. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie J, Chen K, Lee HY, et al: Ultrasmall
c(RGDyK)-coated Fe3O4 nanoparticles and their
specific targeting to integrin alpha(v)beta3-rich tumor cells. J Am
Chem Soc. 130:7542–7543. 2008.PubMed/NCBI
|
|
15
|
Wang RE, Niu Y, Wu H, et al: Development
of NGR peptide-based agents for tumor imaging. Am J Nucl Med Mol
Imaging. 1:36–46. 2011.PubMed/NCBI
|
|
16
|
Albrecht S, Al-Lakkis-Wehbe M, Orsini A,
et al: Amino-benzosuberone: a novel warhead for selective
inhibition of human aminopeptidase-N/CD13. Bioorg Med
Chem. 19:1434–1449. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soudy R, Ahmed S and Kaur K: NGR Peptide
ligands for targeting CD13/APN identified through
peptide array screening resemble fibronectin sequences. ACS Comb
Sci. Oct 11–2012.(Epub ahead of print).
|
|
18
|
Negussie AH, Miller JL, Reddy G, et al:
Synthesis and in vitro evaluation of cyclic NGR peptide targeted
thermally sensitive liposome. J Control Celease. 143:265–273. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sloan EK, Pouliot N, Stanley KL, et al:
Tumor-specific expression of alphavbeta3 integrin promotes
spontaneous metastasis of breast cancer to bone. Breast Cancer Res.
8:R202006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goswami LN, Ma L, Cai Q, et al: cRGD
peptide-conjugated icosahedral closo-B12(2-) core
carrying multiple Gd3+-DOTA chelates for
α(v)β3 integrin-targeted tumor imaging (MRI). Inorg
Chem. 52:1701–1709. 2013.PubMed/NCBI
|
|
21
|
Ndinguri MW, Solipuram R, Gambrell RP, et
al: Peptide targeting of platinum anti-cancer drugs. Bioconjug
Chem. 20:1869–1878. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mishra AK and Chatal JF: Synthesis of
macrocyclic bifunctional chelating agents:
1,4,7-tris(carboxymethyl)-10-(2-aminoethyl)-1,4,7,10-tetraazacyclododecane
and 1,4,8-tris
(carboxymethyl)-11-(2-aminoethyl)-1,4,8,11-tetraazacyclotetradecane.
New J Chem. 25:336–339. 2001. View
Article : Google Scholar
|
|
23
|
Kates SA, Sole NA, Johnson CR, et al: A
novel, convenient, 3-dimensional orthogonal strategy for
solid-phase synthesis of cyclic-peptides. Tetrahedron Lett.
34:1549–1552. 1993. View Article : Google Scholar
|
|
24
|
Sarin VK, Kent SBH, Tam JP and Merrifield
RB: Quantitative monitoring of solid-phase peptide synthesis by the
ninhydrin reaction. Anal Biochem. 117:147–157. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dathe M, Nikolenko H, Klose J and Bienert
M: Cyclization increases the antimicrobial activity and selectivity
of arginine- and tryptophan-containing hexapeptides. Biochemistry.
43:9140–9150. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Colombo G, Curnis F, De Mori GM, et al:
Structure-activity relationships of linear and cyclic peptides
containing the NGR tumor-homing motif. J Biol Chem.
277:47891–47897. 2002. View Article : Google Scholar : PubMed/NCBI
|
